Alicante, Spain

Miguel Yus Astiz


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miguel Yus Astiz: Innovator in Fatty Acid Derivatives

Introduction

Miguel Yus Astiz is a notable inventor based in Alicante, Spain. He has made significant contributions to the field of chemistry, particularly in the synthesis and purification of fatty acid derivatives. His work has implications for pharmaceuticals and enzyme regulation.

Latest Patents

Miguel Yus Astiz holds a patent for "Enantiomers of 2-hydroxy derivatives of fatty acids." This invention pertains to the synthesis and purification of 2-hydroxy derivatives of fatty acids. It also includes a method for separating their enantiomers, which are optical isomers. The patent covers the enantiomers themselves, pharmaceutical compositions that include them, and their applications as medicines. Additionally, it describes an in vitro method for diagnosis, prognosis, and evaluation of the potential use of these molecules in various pathologies. The invention also explores their role in regulating certain enzymes and studying their activity and effects.

Career Highlights

Miguel Yus Astiz is affiliated with the Universitat de les Illes Balears, where he continues to advance his research and innovation in the field of chemistry. His work has garnered attention for its potential applications in medicine and biochemistry.

Collaborations

Miguel has collaborated with notable colleagues, including Pablo Vicente Escribá Ruiz and María Laura Martín. Their combined expertise contributes to the advancement of research in fatty acid derivatives and their applications.

Conclusion

Miguel Yus Astiz is a prominent figure in the field of chemistry, with a focus on fatty acid derivatives and their pharmaceutical applications. His innovative work continues to impact the scientific community and holds promise for future medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…